A carregar...
Establishing a reasonable price for an orphan drug
BACKGROUND: This paper addresses the question of what a reasonable price for an orphan drug is. The research proposes a way to adjust an established payer/HTA body incremental cost-effectiveness threshold (CET) to take account of differences in patient populations and costs of research and developme...
Na minha lista:
| Publicado no: | Cost Eff Resour Alloc |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7472708/ https://ncbi.nlm.nih.gov/pubmed/32908456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-020-00223-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|